Advancements in molecular diagnostics and biomarker testing are facilitating the broader use of targeted therapies in cancer management throughout the region.
The Africa Cancer Targeted Therapy Market size is expected to reach US$ 3,477.6 million by 2031 from US$ 1,733.4 million in 2024. The market is estimated to record a CAGR of 10.5% from 2025 to 2031.
Cancer has emerged as a major public...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek